Investment analysts at Evercore ISI assumed coverage on shares of Xponential Fitness (NYSE:XPOF – Get Rating) in a research note issued on Monday, The Fly reports. The firm set an “outperform” rating and a $34.00 price target on the stock. Evercore ISI’s price target would indicate a potential upside of 68.65% from the stock’s current price.
Several other equities analysts have also commented on XPOF. Robert W. Baird raised their target price on shares of Xponential Fitness from $26.00 to $28.00 in a report on Monday. Roth Capital initiated coverage on shares of Xponential Fitness in a research note on Tuesday, November 16th. They issued a “buy” rating and a $29.00 price target on the stock. Raymond James reduced their price target on shares of Xponential Fitness from $28.00 to $27.00 and set a “strong-buy” rating on the stock in a research note on Friday, March 4th. Finally, Zacks Investment Research downgraded shares of Xponential Fitness from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 9th. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Xponential Fitness presently has an average rating of “Buy” and an average target price of $24.15.
Investors are betting big on a biotech company behind a shocking breakthrough medical discovery…
And you may only get one opportunity in life to invest in something this big this early…
Want the name & ticker symbol?
NYSE:XPOF traded up $0.31 during mid-day trading on Monday, reaching $20.16. 8,144 shares of the company’s stock were exchanged, compared to its average volume of 166,000. Xponential Fitness has a one year low of $9.87 and a one year high of $24.73. The business’s fifty day moving average is $18.41. The company has a debt-to-equity ratio of 80.16, a quick ratio of 0.86 and a current ratio of 0.95.
Xponential Fitness (NYSE:XPOF – Get Rating) last released its quarterly earnings results on Thursday, March 3rd. The company reported ($0.21) EPS for the quarter, hitting analysts’ consensus estimates of ($0.21). Sell-side analysts anticipate that Xponential Fitness will post 0.84 EPS for the current year.
Several large investors have recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. increased its stake in shares of Xponential Fitness by 2.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 24,522 shares of the company’s stock valued at $502,000 after acquiring an additional 658 shares in the last quarter. Citigroup Inc. increased its stake in shares of Xponential Fitness by 119.8% in the 4th quarter. Citigroup Inc. now owns 2,372 shares of the company’s stock valued at $48,000 after acquiring an additional 1,293 shares in the last quarter. Strs Ohio bought a new stake in shares of Xponential Fitness in the 3rd quarter valued at $26,000. Squarepoint Ops LLC increased its stake in shares of Xponential Fitness by 3.3% in the 4th quarter. Squarepoint Ops LLC now owns 103,274 shares of the company’s stock valued at $2,111,000 after acquiring an additional 3,274 shares in the last quarter. Finally, New York State Common Retirement Fund bought a new stake in shares of Xponential Fitness in the 4th quarter valued at $89,000. Institutional investors own 21.40% of the company’s stock.
Xponential Fitness Company Profile (Get Rating)
Xponential Fitness Inc is a curator of boutique fitness brands across multiple verticals. The company built and curated a diversified platform of boutique fitness brands spanning across verticals including Pilates, indoor cycling, barre, stretching, rowing, dancing, boxing, running and yoga. Its portfolio of brands includes Club Pilates, CycleBar, StretchLab, Row House, AKT, YogaSix and STRIDE.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Should you invest $1,000 in Xponential Fitness right now?
Before you consider Xponential Fitness, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Xponential Fitness wasn’t on the list.
While Xponential Fitness currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.